1. Home
  2. NABL vs NUVB Comparison

NABL vs NUVB Comparison

Compare NABL & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NABL
  • NUVB
  • Stock Information
  • Founded
  • NABL 2000
  • NUVB 2018
  • Country
  • NABL United States
  • NUVB United States
  • Employees
  • NABL N/A
  • NUVB N/A
  • Industry
  • NABL Computer Software: Prepackaged Software
  • NUVB Biotechnology: Pharmaceutical Preparations
  • Sector
  • NABL Technology
  • NUVB Health Care
  • Exchange
  • NABL Nasdaq
  • NUVB Nasdaq
  • Market Cap
  • NABL 1.5B
  • NUVB 1.6B
  • IPO Year
  • NABL N/A
  • NUVB N/A
  • Fundamental
  • Price
  • NABL $7.99
  • NUVB $4.96
  • Analyst Decision
  • NABL Buy
  • NUVB Strong Buy
  • Analyst Count
  • NABL 4
  • NUVB 7
  • Target Price
  • NABL $9.31
  • NUVB $8.86
  • AVG Volume (30 Days)
  • NABL 667.1K
  • NUVB 9.3M
  • Earning Date
  • NABL 11-06-2025
  • NUVB 11-03-2025
  • Dividend Yield
  • NABL N/A
  • NUVB N/A
  • EPS Growth
  • NABL N/A
  • NUVB N/A
  • EPS
  • NABL N/A
  • NUVB N/A
  • Revenue
  • NABL $497,665,000.00
  • NUVB $26,748,000.00
  • Revenue This Year
  • NABL $9.79
  • NUVB $283.17
  • Revenue Next Year
  • NABL $8.97
  • NUVB $340.98
  • P/E Ratio
  • NABL N/A
  • NUVB N/A
  • Revenue Growth
  • NABL 8.65
  • NUVB 1137.19
  • 52 Week Low
  • NABL $6.07
  • NUVB $1.54
  • 52 Week High
  • NABL $11.40
  • NUVB $5.55
  • Technical
  • Relative Strength Index (RSI)
  • NABL 50.60
  • NUVB 60.61
  • Support Level
  • NABL $7.56
  • NUVB $4.53
  • Resistance Level
  • NABL $8.74
  • NUVB $5.17
  • Average True Range (ATR)
  • NABL 0.31
  • NUVB 0.45
  • MACD
  • NABL 0.01
  • NUVB -0.05
  • Stochastic Oscillator
  • NABL 34.32
  • NUVB 63.50

About NABL N-able Inc.

N-able Inc is a provider of cloud-based software solutions for managed service providers (MSPs), enabling them to support digital transformation and growth for small and medium-sized enterprises. With a flexible technology platform and powerful integrations, N-able makes it easy for MSPs to monitor, manage, and protect their end-customer systems, data, and networks. The company's growing portfolio of management, security, automation, and data protection solutions is built for IT services management professionals. Geographically, the majority of revenue is from the United States. The company also has a presence in the United Kingdom and all other International regions.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

Share on Social Networks: